Skip to content
Delayed ~15 min

CARL CARLSMED

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Tue 10 Nov 2026 · after market close

What 7 analyst firms say about CARLSMED: their latest ratings, price targets and how far the stock is from them. How it works

14.52 USD−0.80 (−5.22%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+36.0%to the avg target 19.75 USD+5.23 USD
Buy 5 · Hold 1 · Sell 0

6 rated views · 7 analyst/firm records · 7 firms

Latest report12 Oct 2026avg report date 29 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8054
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8053

Recent analyst activity · last 90 days

Our tracked history has 3 reports on CARL from 2 analyst firms in the last 90 days (7 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target.

No firm's latest available rating differs from its previous one.

Latest observed target change: BTIG Research raised its target from $23.00 (set 6 May 2026) to $24.00 on 12 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BTIGRyan ZimmermanBuy12 Oct 202624.00 USD
Goldman SachsDavid RomanBuy9 Apr 2026Conflicting reports · excluded
NeedhamDavid SaxonBuy1 Jul 202617.00 USD
Piper SandlerMatthew O'BrienBuy3 Jun 202618.00 USD
TruistRichard NewitterBuy6 Aug 202620.00 USD
Weiss RatingsUnnamed analyst—11 Aug 2026—
Data feed RESEARCHResearch TeamHold26 Mar 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 08:14 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.